(Circulation. 1998;98:2791-2795.)
© 1998 American Heart Association, Inc.
Brief Rapid Communications |
From the Section of Cardiology (F.A., D.L., A.K., O.G., T.T., R.H., L.L.B., R.R.), the Department of Pathology (D.W.), and the Graduate Program in Cardiovascular Sciences, the DeBakey Heart Center (F.A.), Baylor College of Medicine, Houston, Tex; the James Paton Memorial Hospital, Gander (P.B.), and the Division of Cardiology, Memorial University of Newfoundland, St John's (M.F.), Newfoundland, Canada; and the Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada (M.G.).
BackgroundArrhythmogenic right ventricular dysplasia (ARVD), a familial cardiomyopathy occurring with a prevalence of 1 in 5000, is characterized by replacement of myocytes with fatty and fibrous tissue. Clinical manifestations include structural and functional abnormalities of the right ventricle and arrhythmias, leading to a sudden death rate of 2.5% per year. Four loci have been mapped, but no gene has been identified as yet.
Methods and ResultsWe identified a large family of >200 members
with ARVD segregating as an autosomal dominant trait affecting 10
living individuals. The diagnosis of ARVD was based on international
diagnostic criteria including history, physical
examination, ECG, echocardiogram, right ventricular
angiogram, endomyocardial biopsy, and 24-hour
ambulatory ECG. Blood was collected for DNA from 149 family members.
Analysis of 257 polymorphic microsatellite markers by
genetic linkage excluded previously known loci for ARVD and identified
a novel locus at 3p23. Analysis of an additional 20 markers
further defined the region. A peak logarithm of the odds score of 6.91
was obtained with marker D3S3613 at
=0% recombination. Haplotype
analysis identified a shared region between markers D3S3610 and
D3S3659 of 9.3 cM.
ConclusionsA novel locus for ARVD has been mapped to 3p23 and the region narrowed to 9.3 cM. Identification of the gene will allow genetic screening and a specific diagnosis for a disease with protean nonspecific findings. It should also provide insight fundamental to understanding cardiac chamberspecific gene expression and/or the mechanism of myocyte apoptosis observed in this disease.
Key Words: apoptosis cardiomyopathy death, sudden genetics polymerase chain reaction
This article has been cited by other articles:
![]() |
S. Zumhagen, T. Spieker, J. Rolinck, H. A. Baba, G. Breithardt, W. Bocker, L. Eckardt, M. Paul, T. Wichter, and E. Schulze-Bahr Absence of Pathognomonic or Inflammatory Patterns in Cardiac Biopsies From Patients With Brugada Syndrome Circ Arrhythmia Electrophysiol, February 1, 2009; 2(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moric-Janiszewska and G. Markiewicz-Loskot Review on the genetics of arrhythmogenic right ventricular dysplasia Europace, May 1, 2007; 9(5): 259 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Ellinor, S. Sasse-Klaassen, S. Probst, B. Gerull, J. T. Shin, A. Toeppel, A. Heuser, B. Michely, D. M. Yoerger, B.-S. Song, et al. A Novel Locus for Dilated Cardiomyopathy, Diffuse Myocardial Fibrosis, and Sudden Death on Chromosome 10q25-26 J. Am. Coll. Cardiol., July 4, 2006; 48(1): 106 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Folino, B. Bauce, G. Frigo, and A. Nava Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings Europace, June 1, 2006; 8(6): 423 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, I. Gussak, H. LeMarec, K. Nademanee, A. R. Perez Riera, et al. Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation, February 8, 2005; 111(5): 659 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hodgkinson, P. S. Parfrey, A. S. Bassett, C. Kupprion, J. Drenckhahn, M. W. Norman, L. Thierfelder, S. N. Stuckless, E. L. Dicks, W. J. McKenna, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) J. Am. Coll. Cardiol., February 1, 2005; 45(3): 400 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wichter and G. Breithardt Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: A role for genotyping in decision-making? J. Am. Coll. Cardiol., February 1, 2005; 45(3): 409 - 411. [Full Text] [PDF] |
||||
![]() |
W. P. McNair, L. Ku, M. R.G. Taylor, P. R. Fain, D. Dao, E. Wolfel, L. Mestroni, and the Familial Cardiomyopathy Registry Research Grou SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia Circulation, October 12, 2004; 110(15): 2163 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Ng, D Adlam, R P Keal, and G A Ng Recurrent ventricular tachycardia of non-ischaemic origin J R Soc Med, January 1, 2004; 97(1): 23 - 25. [Full Text] [PDF] |
||||
![]() |
R. Alcalai, S. Metzger, S. Rosenheck, V. Meiner, and T. Chajek-Shaul A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair J. Am. Coll. Cardiol., July 16, 2003; 42(2): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kimura, F. Sakai, Y. Sakomura, M. Fujimura, E. Ueno, N. Matsuda, H. Kasanuki, and N. Mitsuhashi Helical CT Features of Arrhythmogenic Right Ventricular Cardiomyopathy RadioGraphics, September 1, 2002; 22(5): 1111 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. M. Kayser, E. E. van der Wall, M. U. Sivananthan, S. Plein, T. N. Bloomer, and A. de Roos Diagnosis of Arrhythmogenic Right Ventricular Dysplasia: A Review RadioGraphics, May 1, 2002; 22(3): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Protonotarios, A. Tsatsopoulou, A. Anastasakis, E. Sevdalis, G. McKoy, K. Stratos, K. Gatzoulis, K. Tentolouris, C. Spiliopoulou, D. Panagiotakos, et al. Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
C G De Pasquale and W F Heddle Left sided arrhythmogenic ventricular dysplasia in siblings Heart, August 1, 2001; 86(2): 128 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corrado, C. Basso, and G. Thiene Sudden cardiac death in young people with apparently normal heart Cardiovasc Res, May 1, 2001; 50(2): 399 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tiso, D. A. Stephan, A. Nava, A. Bagattin, J. M. Devaney, F. Stanchi, G. Larderet, B. Brahmbhatt, K. Brown, B. Bauce, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) Hum. Mol. Genet., February 1, 2001; 10(3): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Laitinen, K. M. Brown, K. Piippo, H. Swan, J. M. Devaney, B. Brahmbhatt, E. A. Donarum, M. Marino, N. Tiso, M. Viitasalo, et al. Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia Circulation, January 30, 2001; 103(4): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nava, B. Bauce, C. Basso, M. Muriago, A. Rampazzo, C. Villanova, L. Daliento, G. Buja, D. Corrado, G. A. Danieli, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2226 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roberts A perspective: the new millennium dawns on a new paradigm for cardiology--molecular genetics J. Am. Coll. Cardiol., September 1, 2000; 36(3): 661 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
N G Fisher and T J Gilbert Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition Postgrad. Med. J., July 1, 2000; 76(897): 395 - 398. [Abstract] [Full Text] |
||||
![]() |
W. G. Stevenson and H. T. Aretz Case 20-2000- A 61-Year-Old Man with a Wide-Complex Tachycardia N. Engl. J. Med., June 29, 2000; 342(26): 1979 - 1987. [Full Text] [PDF] |
||||
![]() |
F. Calabrese, A. Angelini, G. Thiene, C. Basso, A. Nava, and M. Valente No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy J. Clin. Pathol., May 1, 2000; 53(5): 382 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corrado, G. Fontaine, F. I. Marcus, W. J. McKenna, A. Nava, G. Thiene, and T. Wichter Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy : Need for an International Registry Circulation, March 21, 2000; 101 (11): e101 - e106. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Swan, K. Piippo, M. Viitasalo, P.a. Heikkila, T. Paavonen, K. Kainulainen, J. Kere, P. Keto, K. Kontula, and L. Toivonen Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2035 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
Progress in Mapping Genes for RV Dysplasia Journal Watch Cardiology, February 12, 1999; 1999(212): 10 - 10. [Full Text] |
||||
![]() |
R. Weiss, M. M. Barmada, T. Nguyen, J. S. Seibel, D. Cavlovich, C. A. Kornblit, A. Angelilli, F. Villanueva, D. M. McNamara, and B. London Clinical and Molecular Heterogeneity in the Brugada Syndrome: A Novel Gene Locus on Chromosome 3 Circulation, February 12, 2002; 105(6): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |